Immune damage

In the past one or two decades, with the increase of tumor incidence and treatment progress, the improvement of diagnosis and treatment of autoimmune and other immune-related diseases, the breakthrough and development of organ transplantation, especially the epidemic of HIV / AIDS, immune compromised hosts .ICH) continues to increase and accumulate, becoming a huge global challenge. Infection is the most important factor affecting the course and prognosis of ICH, and lung is the main target organ of infection. There are still many problems in the diagnosis and treatment of ICH pulmonary infections, which require in-depth research. On the other hand, if the existing research results and technologies can be promoted and fully utilized, it is still possible to make clear diagnosis and effective treatment for most patients in the clinic and improve the prognosis.